Impact of Pseudomonas aeruginosa on exacerbation and death in patients with chronic obstructive pulmonary disease.

J. Eklöf (Copenhagen, Denmark), R. Sørensen (Copenhagen, Denmark), T. Ingebrigtsen (Copenhagen, Denmark), P. Sivapalan (Copenhagen, Denmark), I. Achir (Copenhagen, Denmark), J. Bredtoft Boel (Copenhagen, Denmark), J. Bangsborg (Copenhagen, Denmark), C. Ostergaard (Copenhagen, Denmark), R. Dessau (Slagelse, Denmark), U. Stab Jensen (Slagelse, Denmark), A. Browatzki (Hillerød, Denmark), T. Lapperre (Copenhagen, Denmark), J. Janner (Copenhagen, Denmark), U. Møller Weinreich (Aalborg, Denmark), K. Armbruster (Copenhagen, Denmark), T. Wilcke (Copenhagen, Denmark), N. Seersholm (Copenhagen, Denmark), J. Stæhr Jensen (Copenhagen, Denmark)

Source: International Congress 2019 – Airway infection in COPD
Session: Airway infection in COPD
Session type: Thematic Poster
Number: 2887
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Eklöf (Copenhagen, Denmark), R. Sørensen (Copenhagen, Denmark), T. Ingebrigtsen (Copenhagen, Denmark), P. Sivapalan (Copenhagen, Denmark), I. Achir (Copenhagen, Denmark), J. Bredtoft Boel (Copenhagen, Denmark), J. Bangsborg (Copenhagen, Denmark), C. Ostergaard (Copenhagen, Denmark), R. Dessau (Slagelse, Denmark), U. Stab Jensen (Slagelse, Denmark), A. Browatzki (Hillerød, Denmark), T. Lapperre (Copenhagen, Denmark), J. Janner (Copenhagen, Denmark), U. Møller Weinreich (Aalborg, Denmark), K. Armbruster (Copenhagen, Denmark), T. Wilcke (Copenhagen, Denmark), N. Seersholm (Copenhagen, Denmark), J. Stæhr Jensen (Copenhagen, Denmark). Impact of Pseudomonas aeruginosa on exacerbation and death in patients with chronic obstructive pulmonary disease.. 2887

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severe exacerbations of chronic obstructive pulmonary disease (COPD) due to Pseudomonas aeruginosa: resistance to common antibiotics
Source: Eur Respir J 2001; 18: Suppl. 33, 540s
Year: 2001

Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
Source: Eur Respir J 2009; 34: 1072-1078
Year: 2009



Pseudomonas infection and home oxygen therapy can increase readmission in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Management of COPD
Year: 2017

Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Mycoplasma pneumoniae infection and acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence?
Source: Eur Respir J 2002; 19: 387-389
Year: 2002


Bacterial infection-a common cause of acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 576s
Year: 2006

Impacts on Mycoplasma pneumoniae infection in acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 337s
Year: 2003

A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007

Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001

Prevalence and risk factors for Aspergillus spp. colonization in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD): The multi-center FUNGI-COPD study
Source: Annual Congress 2010 - Various aspects of respiratory epidemiology
Year: 2010


Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Bacterial profile of acute infectious exacerbations of chronic obstructive pulmonary disease requiring hospitalization in Greece
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011


The impact of pseudomonas aeruginosa in the sputum of patients presenting with acute COPD exacerbation
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004


Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002



The role of chlamydia pneumoniae infection in acute purulent exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 221s
Year: 2002

The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009